Moreover, CBLL1 silencing on cancer stem cell tumourspheres induces a significant reduction in tumoursphere size, which is accompanied by the downregulation of the stem cell biomarkers LGR5 and c-MYC at both mRNA and protein levels. The gene discussed is MYC; the disease is cancer.